Xi'an Wanlong Pharmaceutical Co., Ltd
As of 18 November 2026, for the company name Xi'an Wanlong Pharmaceutical Co., Ltd as recorded, the chemical-drug catalogue lists 11 active records with this name as holder; 17 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
23 acceptance records as first applicant, grouped into 20 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
苹果酸奈诺沙星氯化钠注射液 · No verified English name 1 records · Latest accepted 2026/10/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602643 | Generic | 2026/10/29 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
固精麦斯哈片 · No verified English name 1 records · Latest accepted 2026/09/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2604910 | Supplement | 2026/09/22 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
妇月康胶囊 · No verified English name 1 records · Latest accepted 2026/09/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2604909 | Supplement | 2026/09/22 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
枣仁安神颗粒 · No verified English name 1 records · Latest accepted 2026/09/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2604905 | Supplement | 2026/09/22 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
消渴灵胶囊 · No verified English name 1 records · Latest accepted 2026/09/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2604906 | Supplement | 2026/09/22 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
骨刺消痛胶囊 · No verified English name 1 records · Latest accepted 2026/09/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2604907 | Supplement | 2026/09/22 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
Ertugliflozin Tablets 1 records · Latest accepted 2026/08/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602091 | Generic | 2026/08/24 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
复方电解质醋酸钠葡萄糖注射液 · No verified English name 1 records · Latest accepted 2025/11/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502340 | Supplement | 2025/11/13 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
Acetate And Glucose Electrolytes Injection 2 records · Latest accepted 2025/08/08
Generic · 2
奥硝唑阴道泡腾片 · No verified English name 2 records · Latest accepted 2024/07/19
Supplement · 2
Morinidazole and Sodium Chloride Injection 1 records · Latest accepted 2024/07/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401971 | Generic | 2024/07/02 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
乌苯美司胶囊 · No verified English name 1 records · Latest accepted 2024/05/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401505 | Generic | 2024/05/18 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
Compound Dextran 40 Injection 1 records · Latest accepted 2023/07/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350584 | Supplement | 2023/07/20 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
Moxifloxacin Hydrochloride And Sodium Chloride Injection 1 records · Latest accepted 2022/08/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201235 | Generic | 2022/08/04 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
奥硝唑胶囊 · No verified English name 2 records · Latest accepted 2022/02/25
Supplement · 2
Epalrestat Tablets 1 records · Latest accepted 2021/10/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101945 | Generic | 2021/10/29 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
Alanyl Glutamine Injection 1 records · Latest accepted 2021/05/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150591 | Supplement | 2021/05/13 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
Tirofiban Hydrochloride And Sodium Chloride Injection 1 records · Latest accepted 2021/04/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150538 | Supplement | 2021/04/14 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
Ornidazole Injection 1 records · Latest accepted 2021/01/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100074 | Generic | 2021/01/19 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
复方电解质葡萄糖注射液(IV) · No verified English name 1 records · Latest accepted 2018/08/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS1700570 | Generic | 2018/08/10 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
Changes in the last 90 days
9 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 7 applicationsNo longer listed under review: 1 applicationNotification delivery: 1 application
- 2026/11/05No longer listed under review
固精麦斯哈片 · No verified English name
CYZB2604910
Fact date: 2026/11/05 · Date added to this site: 2026/11/05
Accepted: 2026/09/22
no longer on the CDE under-review list as of the data cut-off; NMPA published notification delivery for this acceptance number on 2026/11/04; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 26
NMPA · Table row 26 ↗ View source ↗ - 2026/11/04Notification delivery
固精麦斯哈片 · No verified English name
CYZB2604910
Fact date: 2026/11/04 (Publication date) · Publication date: 2026/11/04 · Date added to this site: 2026/11/04
Notification delivered; the specific outcome remains to be checked.
View source · Table row 26 ↗ - 2026/10/29Accepted
苹果酸奈诺沙星氯化钠注射液 · No verified English name
CYHS2602643
Fact date: 2026/10/29 · Date added to this site: 2026/10/30
View source ↗ - 2026/09/22Accepted
固精麦斯哈片 · No verified English name
CYZB2604910
Fact date: 2026/09/22 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/22Accepted
妇月康胶囊 · No verified English name
CYZB2604909
Fact date: 2026/09/22 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/22Accepted
骨刺消痛胶囊 · No verified English name
CYZB2604907
Fact date: 2026/09/22 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/22Accepted
消渴灵胶囊 · No verified English name
CYZB2604906
Fact date: 2026/09/22 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/22Accepted
枣仁安神颗粒 · No verified English name
CYZB2604905
Fact date: 2026/09/22 · Date added to this site: 2026/10/22
View source ↗ - 2026/08/24Accepted
Ertugliflozin Tablets
CYHS2602091
Fact date: 2026/08/24 · Date added to this site: 2026/10/22
View source ↗
Under review
9 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 苹果酸奈诺沙星氯化钠注射液 · No verified English name | CYHS2602643 | Generic | 2026/10/29 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
| 妇月康胶囊 · No verified English name | CYZB2604909 | Supplement | 2026/09/22 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
| 骨刺消痛胶囊 · No verified English name | CYZB2604907 | Supplement | 2026/09/22 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
| 消渴灵胶囊 · No verified English name | CYZB2604906 | Supplement | 2026/09/22 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
| 枣仁安神颗粒 · No verified English name | CYZB2604905 | Supplement | 2026/09/22 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
| Ertugliflozin Tablets | CYHS2602091 | Generic | 2026/08/24 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
| Acetate And Glucose Electrolytes Injection | CYHS2502881 | Generic | 2025/08/08 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
| Acetate And Glucose Electrolytes Injection | CYHS2502880 | Generic | 2025/08/08 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
| 复方电解质葡萄糖注射液(IV) · No verified English name | CYHS1700570 | Generic | 2018/08/10 | Xi'an Wanlong Pharmaceutical Co., Ltd | CDE ↗ |
Catalogue holder records
11 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 复方电解质醋酸钠葡萄糖注射液 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20269061 | 2026/03/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Morinidazole and Sodium Chloride Injection | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20256110 | 2025/12/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 乌苯美司胶囊 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20255830 | 2025/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方电解质醋酸钠葡萄糖注射液 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20233643 | 2023/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 奥硝唑胶囊 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20031257 | 2023/03/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Epalrestat Tablets | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20223840 | 2022/11/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Bicarbonate Ringer’s Injection | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20223659 | 2022/09/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alanyl Glutamine Injection | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20045975 | 2022/06/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ornidazole Injection | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20223391 | 2022/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tirofiban Hydrochloride And Sodium Chloride Injection | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20183306 | 2022/04/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fexofenadine Hydrochloride Tablets | Xi'an Wanlong Pharmaceutical Co., Ltd | Xi'an Wanlong Pharmaceutical Co., Ltd | 国药准字H20080710 | 2021/01/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
17 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 苹果酸奈诺沙星 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20260000779 | I | 2026/09/20 | CDE ↗ |
| 磷酸二氢钾 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20250000028 | A | 2026/08/19 | CDE ↗ |
| 吗啉硝唑 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20240000144 | A | 2025/07/18 | CDE ↗ |
| 盐酸非索非那定 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20220000912 | A | 2024/06/07 | CDE ↗ |
| 盐酸莫西沙星 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20220000473 | I | 2022/07/05 | CDE ↗ |
| 氯化镁 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20210001003 | A | 2023/05/17 | CDE ↗ |
| 醋酸钠 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20210001001 | A | 2025/10/28 | CDE ↗ |
| 氯化钙 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20210000653 | A | 2022/12/16 | CDE ↗ |
| 奥硝唑 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20210000475 | A | 2024/01/17 | CDE ↗ |
| 丙氨酰谷氨酰胺 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20210000408 | A | 2024/01/17 | CDE ↗ |
| 右旋糖酐70 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20190021593 | A | 2025/01/18 | CDE ↗ |
| 右旋糖酐40 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20190021592 | A | 2025/01/18 | CDE ↗ |
| 乌苯美司 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20190006548 | A | 2026/03/25 | CDE ↗ |
| 混合核苷 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20190003376 | A | 2025/07/23 | CDE ↗ |
| L-苹果酸 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20170002320 | A | 2025/07/23 | CDE ↗ |
| 盐酸替罗非班 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20170000788 | A | 2023/06/07 | CDE ↗ |
| 依帕司他 · No verified English name | Xi'an Wanlong Pharmaceutical Co., Ltd | Y20170000638 | A | 2024/11/26 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.